Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2

Most of the current SARS-CoV-2 vaccines are based on parenteral immunization targeting the S protein. Although protective, such vaccines could be optimized by inducing effective immune responses (neutralizing IgA responses) at the mucosal surfaces, allowing them to block the virus at the earliest st...

Descripción completa

Detalles Bibliográficos
Autores principales: Solis-Andrade, Karla I., Gonzalez-Ortega, Omar, Govea-Alonso, Dania O., Comas-Garcia, Mauricio, Rosales-Mendoza, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609574/
https://www.ncbi.nlm.nih.gov/pubmed/36298624
http://dx.doi.org/10.3390/vaccines10101759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609574/
https://www.ncbi.nlm.nih.gov/pubmed/36298624
http://dx.doi.org/10.3390/vaccines10101759

Ejemplares similares